Catalytic alkene skeletal modification for the construction of fluorinated tertiary stereocenters
Jiang, L; Sarró, P; Teo, WJ; Llop, J; Suero, M.
Chem. Sci., 2022, 13, 4327-4333
Core vs. surface labelling of mesoporous silica nanoparticles: advancing the understanding of nanoparticle fate and design of labelling strategies
Ramírez, MdlA.; Martínez-Villacorta, Á.M; Gómez-Vallejo, V; Andreozzi, P; Soler-Illia, G; Llop, J; Moya, SE.
Nanoscale Adv., 2022, 4, 2098-2106
Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 neuronal ceroid lipofuscinosis
Lopez-Fabuel, I; Garcia-Macia, M; Buondelmonte, C; Burmistrova, O; Bonora, N; Alonso-Batan, P; Morant-Ferrando, B; Vicente-Gutierrez, C; Jimenez-Blasco, D; Quintana-Cabrera, R; Fernandez, E; Llop, J; Ramos-Cabrer, P; Sharaireh, A; Guevara-Ferrer, M; Fitzpatrick, L; Thompton, CD; McKay, TR; Storch, S; Medina, DL; Mole, SE; Fedichev, PO; Almeida, A; Bolaños, JP.
Nat. Commun., 2022, 13, 536
Targeting transthyretin in Alzheimer's disease: Drug discovery of small-molecule chaperones as disease-modifying drug candidates for Alzheimer's disease
Cotrina, EY; Santos, LM; Rivas, J; Blasi, D; Leite, JP; Liz, MA; Busquets, MA; Planas, A; Prohens, R; Gimeno, A; Jimenez-Barbero, J; Gales, L; Llop, J; Quintana, J; Cardoso, I; Arsequell, G
Eur. J. Med. Chem., 2021, 226, 113847
Nanoparticles for Cancer Diagnosis, Radionuclide Therapy and Theranostics
Llop, J; Lammers, T.
ACS Nano, 2021, 15, 16974-16981
In Vivo Evaluation of Multifunctional Gold Nanorods for Boron Neutron Capture and Photothermal Therapies
Pulagam, KR; Henriksen-Lacey, M; Uribe, KB; Renero-Lecuna, C; Kumar, J; Charalampopoulou, A; Facoetti, A; Protti, N; Gomez-Vallejo, V; Baz, Z; Kumar, V; Sanchez-Iglesias, A; Altieri, S; Cossio, U; Di Silvio, D; Martinez-Villacorta, AM; de Angulo, AR; Rejc, L; Liz-Marzan, LM; Llop, J
ACS Appl. Mater. Interfaces, 2021, 13, 49589-49601
Meet our advisors: Jordi Llop
Llop, J; Trevorrow, P
J. Label. Compd. Radiopharm., 2021, 64, 497-499
Novel Core-Shell Polyamine Phosphate Nanoparticles Self-Assembled from PEGylated Poly(allylamine hydrochloride) with Low Toxicity and Increased In Vivo Circulation Time
Andreozzi, P; Simó, C; Moretti, P; Porcel, JM; Lüdtke, TU; Ramirez, MdlA; Tamberi, L; Marradi, M; Amenitsch, H; Llop, J; Ortore, MG; Moya, SE.
Small, 2021, 17, 2102211
In Vivo Tracking of the Degradation of Mesoporous Silica through Zr-89 Radio-Labeled Core-Shell Nanoparticles
Bindini, E; Ramirez, MdlA; Rios, X; Cossío, U; Simó, C; Gomez-Vallejo, V; Soler-Illia, G; Llop, J; Moya, SE.
Small, 2021, 17, 2101519
Opposite alterations of 5-HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile
Diez-Alarcia, R; Muguruza, C; Rivero, G; García-Bea, A; Gómez-Vallejo, V; Callado, LF; Llop, J; Martín, A; Meana, JJ.
Transl. Psychiatry, 2021, 11, 302
Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease
Rejc L, Gómez-Vallejo V, Joya A, Moreno O, Egimendia A, Castellnou P, Ríos-Anglada X, Cossío, U, Baz Z, Passannante R, Tobalina-Larrea I, Ramos-Cabrer P, Giralt A, Sastre M,Capetillo-Zarate E, Kosak U, Knez D, Gobec S, Marder M, Martin A, Llop J.
Theranostics, 2021, 11, 6542-6559
Interfacial activity of modified dextran polysaccharide to produce enzyme-responsive oil-in-water nanoemulsions
Navascuez, M; Gracia, R; Marradi, M; Diaz, N; Rodriguez, J; Loinaz, I; Lopez-Gallego, F; Llop, J; Dupin, D
Chem. Commun., 2021, 57, 4540-4543